RxDoctor Payments Data

Robert Dodge

Adult Health · Raleigh, NCNPI 1295721710

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $230,697 of the $310,818 with a category attached, or 74.2%. Viiv Healthcare Company accounts for 69.3% of it on its own, with 8 other manufacturers making up the rest. Among adult health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$310,818in general payments, 2019–2025

Across 851 payments — averaging $365.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$215K
  • Gilead$63K
  • Merck$17K
  • Janssen Products, LP$12K
  • Janssen Scientific Affairs, LLC$1K
  • Johnson & Johnson$740
  • plus $971 from 3 others

What the payments were for

  • Consulting fees$19,0616%
  • Speaking & faculty fees$230,69774%
  • Travel & lodging$41,90713%
  • Food & beverage$18,8896%
  • Education$2650%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$310,818 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala229$955,247
DovatoDolutegravir Sodium/Lamivudine52$158,534
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf23$108,771
CabenuvaCabotegravir/Rilpivirine13$95,584
TriumeqAbacavir/Dolutegravir/Lamivudi19$78,039
OzempicSemaglutide17$31,884
DescovyEmtricitabine/Tenofov Alafenam11$27,983
FarxigaDapagliflozin Propanediol38$27,557
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$14,707
ValacyclovirValacyclovir Hcl105$5,500
Testosterone35$3,982
Insulin Lispro Kwikpen U-100Insulin Lispro12$1,958
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid20$1,662
Ramelteon15$1,610
Albuterol Sulfate HfaAlbuterol Sulfate45$1,257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy$63,060$983,230240 claims
Viiv Healthcare CompanyDovato, Cabenuva, Triumeq$215,458$332,15784 claims
Janssen Products, LPSymtuza$11,905$108,77123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 adult health providers in North Carolina.

Other adult health in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →